These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 25517904)
1. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery. Mehra NK; Jain NK Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904 [TBL] [Abstract][Full Text] [Related]
2. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702 [TBL] [Abstract][Full Text] [Related]
3. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes. Mehra NK; Jain NK J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734 [TBL] [Abstract][Full Text] [Related]
4. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682 [TBL] [Abstract][Full Text] [Related]
5. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Mehra NK; Verma AK; Mishra PR; Jain NK Biomaterials; 2014 May; 35(15):4573-88. PubMed ID: 24612818 [TBL] [Abstract][Full Text] [Related]
6. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Wen S; Liu H; Cai H; Shen M; Shi X Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549 [TBL] [Abstract][Full Text] [Related]
7. Effect of functionalization on drug delivery potential of carbon nanotubes. Sharma S; Mehra NK; Jain K; Jain NK Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1851-1860. PubMed ID: 26732473 [TBL] [Abstract][Full Text] [Related]
8. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555 [TBL] [Abstract][Full Text] [Related]
9. Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors. Yan Y; Wang R; Hu Y; Sun R; Song T; Shi X; Yin S Drug Deliv; 2018 Nov; 25(1):1607-1616. PubMed ID: 30348025 [TBL] [Abstract][Full Text] [Related]
10. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation. Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496 [TBL] [Abstract][Full Text] [Related]
11. Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes. Mehra NK; Jain NK Colloids Surf B Biointerfaces; 2015 Aug; 132():17-26. PubMed ID: 26001798 [TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550 [TBL] [Abstract][Full Text] [Related]
13. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment. Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Datir SR; Das M; Singh RP; Jain S Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830 [TBL] [Abstract][Full Text] [Related]
15. Single-walled carbon nanotube-loaded doxorubicin and Gd-DTPA for targeted drug delivery and magnetic resonance imaging. Yan C; Chen C; Hou L; Zhang H; Che Y; Qi Y; Zhang X; Cheng J; Zhang Z J Drug Target; 2017 Feb; 25(2):163-171. PubMed ID: 27499100 [TBL] [Abstract][Full Text] [Related]
16. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery. Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742 [TBL] [Abstract][Full Text] [Related]
17. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index. Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964 [TBL] [Abstract][Full Text] [Related]
19. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Lu YJ; Wei KC; Ma CC; Yang SY; Chen JP Colloids Surf B Biointerfaces; 2012 Jan; 89():1-9. PubMed ID: 21982868 [TBL] [Abstract][Full Text] [Related]
20. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy. Wu G; Wang Z; Bian X; Du X; Wei C Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]